Also trades as: SMSPHARMA.NS (NSE) · $vol 3M
SMSPHARMA.BO BSE
SMS Pharmaceuticals Limited
1W: -0.6%
1M: +27.7%
3M: +11.1%
YTD: +47.9%
1Y: +103.6%
3Y: +294.9%
5Y: +157.1%
₹485.00 ($5.04)
+13.40 (+2.84%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$379M
-41.2% ▼
5Y CAGR: -16.0%
Capital Expenditures
$1.3B
-5.8% ▼
5Y CAGR: -3.0%
Free Cash Flow
-$926M
-57.4% ▼
Dividends Paid
$35M
-4.7% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$46M
-14.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $685M | $53M | $498M | $691M | $1.0B |
| Depreciation & Amort. | $322M | $321M | $315M | $343M | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$593M | -$313M | -$545M | -$431M | -$940M |
| Other Non-Cash Items | -$11M | $163M | $233M | $41M | $299M |
| Operating Cash Flow | $402M | $224M | $501M | $645M | $379M |
| — Investing Activities — | |||||
| Capital Expenditures | -$272M | -$299M | -$522M | -$1.2B | -$1.3B |
| Acquisitions (Net) | $171K | $3M | $0 | $560K | $0 |
| Investment Purchases | -$2M | -$980K | $0 | -$149K | $0 |
| Investment Sales | $2M | -$3M | $0 | $0 | $0 |
| Other Investing | $944K | $3M | $880K | -$3M | -$10M |
| Investing Cash Flow | -$272M | -$297M | -$521M | -$1.2B | -$1.3B |
| — Financing Activities — | |||||
| Net Debt Issuance | $94M | -$78M | $275M | $304M | $541M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$25M | -$25M | -$25M | -$34M | -$35M |
| Other Financing | -$138M | -$217M | -$228M | -$7M | $0 |
| Financing Cash Flow | -$69M | -$320M | $307M | $644M | $981M |
| Net Change in Cash | $62M | -$392M | $287M | $54M | $46M |
| Cash End of Period | $466M | $74M | $360M | $416M | $461M |
| Free Cash Flow | $130M | -$75M | -$20M | -$589M | -$926M |